North America - United States • Dispute resolution
Venable LLP
We only have limited information for this firm. Consider the following firms which have provided more information:
Co-headed from Baltimore by Kathleen Hardway and Jason Rose , Venable LLP‘s product liability and mass tort group has over the years developed particular expertise in the life sciences sector, marrying subject matter and regulatory prowess with a deep understanding of effective litigation tactics. Consequently, the team regularly secures leadership roles on large aggregated litigation, including acting as national counsel responsible for shaping the overarching management and strategy of MDLs. The firm’s role as co-counsel to Takeda in litigation related to its PPI medications remains a highlight of the practice, with Rose, Craig Thompson and Bruce Parker , all having pivotal roles in the matter and successfully guiding the firm to securing the dismissal of the majority of cases filed in Delaware. One of the specialized areas of practice that the firm excels in is representing vaccine manufacturers who face allegations of vaccine injury, where Dino Sangiamo is particularly skilled.
Legal 500 Editorial commentary
Key clients
- Merck & Co., Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
Abbreviated data is displayed for this firm.
Work highlights
- Acting as Merck’s national counsel in litigation related to its shingles vaccine, Zostavax.
- Serving as co-national counsel to Takeda for litigation related to its proton-pump inhibitor (PPI) medications, including Prevacid and Dexilant, which treat acid reflux/GERD. In this litigation, plaintiffs allege that Takeda’s PPI medications cause certain kidney injuries.
Abbreviated data is displayed for this firm.